Abstract B105: ACTR707: a novel T-cell therapy for the treatment of relapsed or refractory CD20+ B cell lymphoma in combination with rituximab
Motz, Greg, Whiteman, Kathleen, Shin, John, Pai, Tapasya, Judge, Casey, Barnitz, Anthony, Hemphill, James, Kim, James, Ranger, Ann, Huet, Heather, McGinness, Kathleen, Schultes, Birgit, Hodge, Geoffrey, Vasconcelles, Michael, Ettenberg, Seth
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Targeting CD20+ Relapsed Refractory B Cell Lymphoma with ACTR087, Antibody-Coupled T-Cell Receptor (ACTR) Engineered Autologous T Cells, in Combination with Rituximab
Huet, Heather A, Judge, Casey, Barnitz, R. Anthony, Boomer, Ryan, McGinness, Kathleen, Shin, John, Cheema, Tooba, Whiteman, Kathleen, Schultes, Birgit, Ranger, Ann, Cao, Lan, Hodge, Geoffrey, Vasconcelles, Michael J., Ettenberg, Seth A
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Continuous perfusion bioreactor system
Mardirosian, Dan, Guertin, Patrick, Hodge, Geoffrey, Fisher, Michael, Galliher, Parrish
Year of Publication 17.05.2023
Get full text
Year of Publication 17.05.2023
Patent